Rodérau O.
- Country
- France
- Department
- Service de médecine interne
Research Overview
- Rituximab Maintenance Therapy versus Placebo in Patients with Stabilized Systemic Sclerosis–Associated Interstitial Lung Disease after Induction
- Phase II Randomized Double‑Blind Placebo‑Controlled Study of Intravenous Obinutuzumab in Patients with Diffuse Systemic Sclerosis
- Phase III Randomized Double‑Blind Trial of Elecoglipron (AZD5004) on Cardiovascular Mortality and Hospitalization in Adults with HFpEF or HFmrEF on Background Dapagliflozin
Data & Insights
Has run more than one trial at 53 of 271 partner sites.
Specializations
Vasculitis Management
This investigator specializes in treating various forms of vasculitis, with particular focus on granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Their research explores innovative therapeutic approaches including rituximab-based treatments and maintenance strategies.
- ANCA-associated vasculitis treatment protocols
- Remission maintenance strategies
- Extended prednisone administration studies
The investigator evaluates various treatment combinations to optimize patient outcomes in complex vasculitis cases.
Autoimmune Conditions
Their expertise extends to managing severe autoimmune conditions, particularly Giant Cell Arteritis (GCA) and Behçet's disease. The investigator studies comparative effectiveness of biological therapies including tocilizumab and adalimumab.
- Sight-threatening uveitis treatment
- Biological therapy optimization
- Treatment discontinuation protocols
Research focuses on developing effective treatment strategies for complex autoimmune manifestations.
Specialized Therapeutic Approaches
The investigator conducts research on eosinophilic granulomatosis with polyangiitis (EGPA), exploring novel treatment regimens including mepolizumab-based therapies. Their work includes evaluation of glucocorticoid-sparing strategies.
- Biological therapy applications
- Alternative treatment pathways
- Salvage therapy protocols
Emphasis is placed on developing targeted therapeutic approaches for treatment-resistant conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.